Cerebral radiation necrosis

Neurologist

Volumn 9, Issue 4, 2003, Pages 180-188

  Giglio, Pierre ^b   Gilbert, Mark R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

Cognitive dysfunction; Necrosis; Radiation

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CARBON 11; CORTICOSTEROID; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; HEPARIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHIONINE DERIVATIVE; METHYLPHENIDATE; MODAFINIL; PENTOXIFYLLINE; PSYCHOSTIMULANT AGENT; RUBIDIUM 82; STEROID; THALLIUM 201; THYMIDINE DERIVATIVE; TICLOPIDINE; TRACER; WARFARIN;

ACUTE DISEASE; ANTICOAGULANT THERAPY; AUTOPSY; BLEEDING; BRAIN BIOPSY; BRAIN CANCER; BRAIN FUNCTION; BRAIN NECROSIS; BRAIN PERFUSION; BRAIN RADIATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL LOSS; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY DIAGNOSIS; EVOLUTION; FUNCTIONAL ASSESSMENT; GLUCOSE INTOLERANCE; HUMAN; HYPERBARIC OXYGEN; HYPOPITUITARISM; HYPOTHYROIDISM; INCIDENCE; INTERMETHOD COMPARISON; MYOPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR MEDICINE; OSTEOPENIA; PATHOGENESIS; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COUNSELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURY; RADIATION NECROSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

AUTOPSY; BRAIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; NECROSIS; RADIATION INJURIES; RADIOTHERAPY;

EID: 0043124702     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000080951.78533.c4     Document Type: Review

References (44)

1. Davidoff LM, Dyke CG, Elsberg CA, Tarlov IM. The effect of radiation applied directly to the brain and spinal cord. Experimental investigations on the Macacus Rhesus monkeys. Radiology. 1938;31:451.
2. Arnold A, Bailey P. Alterations in the glial cells following irradiation of the brain in primates. Arch Path. 1954;57:383.
3. Russell DS, Wilson CW, Tansley K. Experimental radionecrosis of the brain in rabbits. J Neurol Neurosurg Psychiat. 1949;12:187.
4. Lowenberg-Scharenberg K, Bassett RC. Amyloid degeneration of the human brain following x-ray therapy. J Neurpath Exp Neurol. 1950;9:93
5. 60 (Gamma) radiation. Arch Path. 1959;68:322.
6. Nielsen SL, Kjellberg RN, Asbury AK, Koehler AM. Neuropathologic effects of proton-beam irradiation in man: evaluation after primary irradiation. Acta Neurpath. (Berl) 1972;21:76.
7. Pennybacker J, Russell DS. Necrosis of the brain due to radiation therapy: clinical and pathological observations. J Neurol Neurosurg Psychiat. 1948;11:183.
8. Eyster EF, Nielsen SL, Sheline GE, Wilson CB. Cerebral radiation necrosis simulating a brain tumor. J Neurosurg. 1974;39:267.
9. Ghatak NR, White BE. Delayed radiation necrosis of the hypothalamus. Report of a case simulating recurrent cramopharyngioma. Arch Neurol. (Chic) 1969;21:425.
10. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980;6:1215-1228.
11. Imperato JP, Paleologos NA, Vick NA. Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol. 1990;28:818-822.
12. Burger PC, et al. Encephalomyopathy following high-dose BCNU therapy. Cancer 1981;48:1318-1327.
13. Kumar AJ, Leeds NE, Fuller GN. Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-384.
14. Calvo W, Hopewell JW, Reinhold HS, Yeung TK. Time- and dose- related changes in the white matter of the rat brain after single doses of X-rays. Br J Biol. 1988;61:1043-1052.
15. Hopewell JW, von der Kogel AJ. Pathophysiological mechanisms leading to the development of the radiation-induced damaged to the central nervous system. In: Weigel T, Hinkelbein W. Brock M, Hoell T, eds. Controversies in Neuro-Oncology. Basel, Karger, Front Radiat Ther Oncol 1999;(33):265-275.
16. Burger PC, Boyko OB. The pathology of central nervous system radiation injury. In: Gutin PH, Leibel SA, Sheline GE, eds. Radiation injury to the nervous system. New York: Raven; 1991:191-208.
17. Sawaya R. The fibrinolytic enzymes in the biology of brain tumors. In: Sawaya MD, ed. Fibrinolysis and the Central Nervous System. Philadelphia, PA: Hanley & Belfus; 1990:106-126.
18. Meyers CA. Quality of life of brain tumor patients. In: Bernstein M., Berger MS, eds. Neuro-Oncology The Essentials, New York: Thieme Medical Publishers, Inc.; 2000:XX-XX.
19. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. Am J Neuroradiol. 2000;21:901-909.
20. Hazle JD, Jackson EF, Schomer DF, Leeds NE. Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J Magn Reson Imaging. 1997;7(6):1084-1093.
21. Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 1997;87(4):525-534.
22. Lin A, Blum LS, Mamelak AN. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999;45(1):69-81.
23. Dowling C, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol. 2001;22:604-612.
24. Hall WA, Martin A, Liu H, Truwit CL. Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with real-time needle placement. J Magn Reson Imaging. 2001;13(1):12-15.
25. Tsui EY, Chan JH, Ramsey RG, et al. Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: evaluation with combined multi-section diffusion-weighted and perfusion weighted MR imaging. Eur J Radiol. 2001;39(3):133-138.
26. Black KL, Hawkins RA, Kin KT, et al. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg. 1989;71:342-346.
27. rd, Loeffler JS, Folkerth R, Holman BL. Am J Neuroradiol. 1991;12(6):1187-1192.
28. Kline JL, Noto RB, Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery of conventional radiation therapy. Am J Neuroradiol. 1996;17(9):1681-1686.
29. Moody EB, Hodes JE, Walsh JW, Thornsberry S. Thallium-avid cerebral radiation necrosis. Clin Nucl Med. 1994;19(7):611-613.
30. Yoshii Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M. Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. Am J Neuroradiol. 1996;17(9):1773-1776.
31. de Vries B, Taphoorn MJ, van Isselt JW, Terhaard CH, Jansen GH, Elsenburg PH. Bilateral temporal lobe necrosis after radiotherapy: confounding SPECT results. Neurology. 1998;51(4):1183-1834.
32. Patronas NJ, DiChio G, Brooks RA, et al. Work in progress: 18F fluorodeocyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology. 1982;144:885-888.
33. Doyle WK, Budinger TF, Valk PE, Levin VA, Gutin PH. Differentiation of cerebral radiation necrosis from tumor recurrence by 18F FDG and 82 Rb positron emission tomography. J Comput Assist Tomogr. 1987;11(4):563-570.
34. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg. 1988;69(6):830-838.
35. Mogard J, Kihlstrom L, Ericson K, Karlsson B, Guo WY, Stone-Elander S. J Comput Assist Tomogr. 1994;18(2):177-181.
36. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography. Am J Neuroradiol. 1998;19(3):407-413.
37. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Sterotact Funct Neurosurg. 1999;73(1-14):9-14.
38. Chao ST, Suh JH, Raja S, Lee S-Y, Barnett G. The sensitivity and specificity of FDG PET in distinguishing brain tumor from radionecrosis in patients treated with sterotactic radiosurgery. Int J Cancer. 2001;96(3):191-197.
39. Yashino E, et al. Irradiation effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy. Stereotact Funct Neurosurg. 1996;66(suppl 1):240-259.
40. Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen M, Kirchner PT. Diagnosis of recurrent brain tumor: value of 201 T1 SPECT vs fluorodeoxyglucose PET. Am J Roentgenol. 1994;163(6):1459-1465.
41. Stokkel M, Stevens H, Taphoorn M, Van Rijk P. Differentiation between recurrent brain tumor and post-radiation necrosis: the value of 201 T1 SPET versus 18F-FDG PET using a dual-headed concidence camera - apilot study. Nucl Med Commun. 1999;20:411-7.
42. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994;44(1):2020-2027.
43. Chuba PJ, Anonon P, Bhambhani K, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer. 1997;80(10):2005-2012.
44. Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate improves cognition, mood and function of brain tumor patients. J Clin Oncol. 1998;16:2522-2527.